%2C%20Inc./other/PharmaBlock_Sciences_Nanjing_Inc.-logo.png){kind=logo}
PharmaBlock Sciences (Nanjing), Inc. — Investor Relations & Filings
PharmaBlock Sciences (Nanjing), Inc. specializes in the design and manufacture of innovative building blocks and provides integrated chemistry services for drug discovery and development. The company offers a comprehensive portfolio of structurally diverse scaffolds and intermediates used to enhance the efficiency of medicinal chemistry. Its core capabilities include process research and development, scale-up production, and commercial-scale manufacturing under CDMO frameworks. By utilizing advanced chemical technologies and a vast library of unique chemical entities, the company supports global biotechnology and pharmaceutical organizations in streamlining their research pipelines and optimizing the transition from discovery to clinical development and commercialization.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 2025年度股东会决议公告 | 2026-05-12 | Chinese | |
| 药石科技2025年度股东会法律意见书 | 2026-05-12 | Chinese | |
| 2025年度募集资金存放、管理与使用情况的专项报告 | 2026-04-21 | Chinese | |
| 关于2026年度开展外汇衍生品交易预计及授权的公告 | 2026-04-21 | Chinese | |
| 第四届董事会第十三次会议决议公告 | 2026-04-21 | Chinese | |
| 2026年一季度报告 | 2026-04-21 | Chinese |
Browse filings by year
10 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
15 filings
| |||||
| 45220508 | 2025年度股东会决议公告 | 2026-05-12 | Chinese | ||
| 45220499 | 药石科技2025年度股东会法律意见书 | 2026-05-12 | Chinese | ||
| 40025117 | 2025年度募集资金存放、管理与使用情况的专项报告 | 2026-04-21 | Chinese | ||
| 40025115 | 关于2026年度开展外汇衍生品交易预计及授权的公告 | 2026-04-21 | Chinese | ||
| 40025114 | 第四届董事会第十三次会议决议公告 | 2026-04-21 | Chinese | ||
| 40025112 | 2026年一季度报告 | 2026-04-21 | Chinese | ||
| 40025110 | 非经营性资金占用及其他关联资金往来情况汇总表的专项说明 | 2026-04-21 | Chinese | ||
| 40025107 | 非经营性资金占用及其他关联资金往来情况汇总表 | 2026-04-21 | Chinese | ||
| 40025105 | 2025年年度审计报告 | 2026-04-21 | Chinese | ||
| 40025102 | 2025年年度报告 | 2026-04-21 | Chinese | ||
| 40025096 | 南京药石科技股份有限公司2025年年度财务报告 | 2026-04-21 | Chinese | ||
| 40025094 | 2025年年度报告摘要 | 2026-04-21 | Chinese | ||
| 40025091 | 关于2022年限制性股票激励计划作废部分已授予但尚未归属的限制性股票的公告 | 2026-04-21 | Chinese | ||
| 40025089 | 华泰联合证券有限责任公司关于南京药石科技股份有限公司2025年度募集资金存放与实际使用情况的核查意见 | 2026-04-21 | Chinese | ||
| 40025087 | 董事会审计委员会2025年度履职报告 | 2026-04-21 | Chinese | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
ADLINE CHEM LAB LIMITED
Produces APIs, chemical intermediates, and specialty chemic…
|
524604 | IN | Manufacturing |
|
ADMA BIOLOGICS, INC.
Biopharmaceutical company that develops and manufactures pl…
|
ADMA | US | Manufacturing |
|
Advectus Life Sciences Inc.
Advances drug delivery systems using proprietary nanopartic…
|
AVXSF | CA | Manufacturing |
|
Adverum Biotechnologies, Inc.
A clinical-stage company developing gene therapies for ocul…
|
ADVM | US | Manufacturing |
|
Advicenne
A specialty pharmaceutical company developing treatments fo…
|
ALDVI | FR | Manufacturing |
|
AegirBio AB
A diagnostics company specializing in therapeutic drug moni…
|
AEGIR | SE | Manufacturing |
|
Aelis Farma
Biopharmaceutical company developing CB1 receptor inhibitor…
|
AELIS | FR | Manufacturing |
|
AEON Biopharma, Inc.
Clinical-stage company developing therapeutic applications …
|
AEON | US | Manufacturing |
|
Aequus Pharmaceuticals Inc.
Developing and commercializing specialty pharmaceutical pro…
|
AQS | CA | Manufacturing |
|
AFC-HD AMS Life Science Co.,Ltd.
An OEM of health foods, supplements, and cosmetics with int…
|
2927 | JP | Manufacturing |
PharmaBlock Sciences (Nanjing), Inc. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/55702/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=55702 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=55702 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=55702 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 55702}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for PharmaBlock Sciences (Nanjing), Inc. (id: 55702)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.